REVLIMID® (lenalidomide) logo

This site is intended for US audiences only.

This site is intended for US audiences only.

REVLIMID® (lenalidomide) is a prescription medicine, used to treat adults with multiple myeloma (MM) in combination with the medicine dexamethasone, or as maintenance treatment after autologous hematopoietic stem cell transplantation (a type of stem cell transplant that uses your own stem cells). REVLIMID should not be used to treat people who have chronic lymphocytic leukemia (CLL) unless they are participants in a controlled clinical trial. It is not known if REVLIMID is safe and effective in children.

Back to Top

The REMS Companion App

Easily access the
Lenalidomide REMS program.

Download now

Real patients tell their treatment stories

Allan, a former REVLIMID® (lenalidomide) patient with multiple myeloma

DIAGNOSIS

Allan shares how he felt when his doctor diagnosed his multiple myeloma.

Watch Now

Allan is no longer taking REVLIMID.

Julie, a former REVLIMID® (lenalidomide) patient with multiple myeloma

TREATMENT

Julie talks about the conversation she had with her doctor that led her to REVLIMID.

Watch Now

Julie is no longer taking REVLIMID.

Tiffany, a REVLIMID® (lenalidomide) patient with multiple myeloma

Maintenance

Tiffany describes her experience taking REVLIMID as a maintenance therapy.

Watch Now

Tiffany is currently taking REVLIMID.

Thomas, a former REVLIMID® (lenalidomide) patient with multiple myeloma

RELAPSE

Thomas shares what motivates him to keep fighting even after his relapse.

Watch Now

Thomas is no longer taking REVLIMID.

Allan, Julie, Tiffany, and Thomas were each compensated for their time by Celgene Corporation, a Bristol Myers Squibb company.